Spots Global Cancer Trial Database for procarbazine hydrochloride
Every month we try and update this database with for procarbazine hydrochloride cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease | NCT00004010 | Lymphoma | bleomycin sulfa... filgrastim ABVD regimen cyclophosphamid... dacarbazine doxorubicin hyd... etoposide prednisone procarbazine hy... vinblastine sul... vincristine sul... radiation thera... | - 21 Years | Children's Oncology Group | |
Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma | NCT00002840 | Brain and Centr... | lomustine procarbazine hy... vincristine sul... radiation thera... | 16 Years - 69 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
Combination Chemotherapy in Treating Children With Progressive Brain Tumors | NCT00002944 | Brain Tumors Central Nervous... | carboplatin lomustine procarbazine hy... thioguanine vincristine sul... | - 9 Years | Children's Oncology Group | |
Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma | NCT00003101 | Brain and Centr... | filgrastim busulfan lomustine procarbazine hy... thiotepa vincristine sul... autologous bone... peripheral bloo... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma | NCT00003929 | Lymphoma | filgrastim lomustine procarbazine hy... radiation thera... | - | Case Comprehensive Cancer Center | |
Procarbazine in Treating Patients With Recurrent Brain Tumor | NCT00004004 | Brain and Centr... | procarbazine hy... | 18 Years - | National Cancer Institute (NCI) | |
Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma | NCT00003929 | Lymphoma | filgrastim lomustine procarbazine hy... radiation thera... | - | Case Comprehensive Cancer Center | |
Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma | NCT00003375 | Brain and Centr... | lomustine procarbazine hy... vincristine sul... radiation thera... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma | NCT00079092 | Brain and Centr... | procarbazine hy... thalidomide | 18 Years - 120 Years | Wake Forest University Health Sciences | |
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab | NCT05675410 | Lugano Classifi... | Biospecimen Col... Bleomycin Sulfa... Brentuximab Ved... Computed Tomogr... Cyclophosphamid... Dacarbazine Doxorubicin Hyd... Etoposide Etoposide Phosp... Fludeoxyglucose... Involved-site R... Magnetic Resona... Nivolumab Positron Emissi... Prednisolone Prednisone Procarbazine Hy... Questionnaire A... Vinblastine Sul... Vincristine Sul... | 5 Years - 60 Years | National Cancer Institute (NCI) | |
A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years | NCT00079105 | Lymphoma | bleomycin sulfa... cyclophosphamid... etoposide mitoxantrone hy... prednisolone procarbazine hy... vinblastine sul... | 60 Years - 120 Years | Newcastle-upon-Tyne Hospitals NHS Trust | |
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma | NCT00822120 | Lymphoma Nonneoplastic C... | bleomycin sulfa... filgrastim ABVD regimen BEACOPP regimen cyclophosphamid... dacarbazine doxorubicin hyd... etoposide prednisone procarbazine hy... vinblastine sul... vincristine sul... | 18 Years - 60 Years | SWOG Cancer Research Network | |
Combination Chemotherapy in Treating Children With Progressive Brain Tumors | NCT00002944 | Brain Tumors Central Nervous... | carboplatin lomustine procarbazine hy... thioguanine vincristine sul... | - 9 Years | Children's Oncology Group | |
RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease | NCT00002462 | Lymphoma | bleomycin sulfa... doxorubicin hyd... mechlorethamine... prednisone procarbazine hy... vinblastine sul... vincristine sul... low-LET cobalt-... low-LET photon ... radiation thera... | 15 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
Procarbazine in Treating Patients With Recurrent Brain Tumor | NCT00004004 | Brain and Centr... | procarbazine hy... | 18 Years - | National Cancer Institute (NCI) | |
Procarbazine in Treating Patients With Recurrent Brain Tumor | NCT00004004 | Brain and Centr... | procarbazine hy... | 18 Years - | National Cancer Institute (NCI) | |
Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma | NCT00379041 | Lymphoma | bleomycin sulfa... doxorubicin hyd... mechlorethamine... prednisone procarbazine hy... vinblastine sul... vincristine sul... radiation thera... | 15 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma | NCT00049439 | Lymphoma | filgrastim cyclophosphamid... etoposide lomustine procarbazine hy... | 16 Years - | Case Comprehensive Cancer Center | |
RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease | NCT00002462 | Lymphoma | bleomycin sulfa... doxorubicin hyd... mechlorethamine... prednisone procarbazine hy... vinblastine sul... vincristine sul... low-LET cobalt-... low-LET photon ... radiation thera... | 15 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas | NCT00003564 | Brain and Centr... | Isotretinoin Procarbazine Hy... | 16 Years - | M.D. Anderson Cancer Center | |
Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma | NCT00003101 | Brain and Centr... | filgrastim busulfan lomustine procarbazine hy... thiotepa vincristine sul... autologous bone... peripheral bloo... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma | NCT00678327 | Lymphoma | bleomycin sulfa... filgrastim pegfilgrastim cyclophosphamid... dacarbazine doxorubicin hyd... etoposide prednisolone procarbazine hy... vinblastine sul... vincristine sul... | 18 Years - 100 Years | University College, London | |
Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma | NCT00433459 | Lymphoma | cyclophosphamid... dacarbazine prednisolone prednisone procarbazine hy... vincristine sul... fludeoxyglucose... radiation thera... | - 17 Years | Martin-Luther-Universität Halle-Wittenberg | |
Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma | NCT01132807 | Lymphoma | Bleomycin Sulfa... Doxorubicin Hyd... Procarbazine Hy... Vinblastine Sul... Dacarbazine Cyclophosphamid... Etoposide phosp... prednisone Radiation Thera... Fludeoxyglucose... computed tomogr... Positron Emissi... | 18 Years - 60 Years | Alliance for Clinical Trials in Oncology | |
Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL | NCT00734773 | Brain and Centr... Lymphoma Neurotoxicity | Rituximab Cytarabine Methotrexate Motexafin gadol... Procarbazine hy... Vincristine sul... Radiation thera... | 18 Years - | Northwestern University | |
SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme | NCT00003293 | Brain and Centr... | leflunomide procarbazine hy... | 18 Years - | Pfizer | |
Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma | NCT00049439 | Lymphoma | filgrastim cyclophosphamid... etoposide lomustine procarbazine hy... | 16 Years - | Case Comprehensive Cancer Center | |
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma | NCT00002806 | Brain and Centr... | lomustine procarbazine hy... vincristine sul... low-LET photon ... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma | NCT00074191 | Lymphoma | cytarabine dexamethasone lomustine methotrexate procarbazine hy... | 16 Years - 75 Years | OHSU Knight Cancer Institute | |
Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma | NCT00079092 | Brain and Centr... | procarbazine hy... thalidomide | 18 Years - 120 Years | Wake Forest University Health Sciences | |
Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas | NCT00003113 | Lymphoma | filgrastim cyclophosphamid... etoposide lomustine procarbazine hy... radiation thera... | 60 Years - | Case Comprehensive Cancer Center | |
Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors | NCT00002463 | Brain and Centr... | MOPP Regimen Leucovorin Calc... Mechlorethamine... Methotrexate Prednisone Procarbazine Hy... Vincristine Sul... Conventional Su... | - 3 Years | M.D. Anderson Cancer Center | |
Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas | NCT00003788 | Brain and Centr... | carmustine lomustine porfimer sodium procarbazine hy... neoadjuvant the... surgical proced... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors | NCT00002463 | Brain and Centr... | MOPP Regimen Leucovorin Calc... Mechlorethamine... Methotrexate Prednisone Procarbazine Hy... Vincristine Sul... Conventional Su... | - 3 Years | M.D. Anderson Cancer Center | |
Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma | NCT00003101 | Brain and Centr... | filgrastim busulfan lomustine procarbazine hy... thiotepa vincristine sul... autologous bone... peripheral bloo... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas | NCT00003564 | Brain and Centr... | Isotretinoin Procarbazine Hy... | 16 Years - | M.D. Anderson Cancer Center | |
Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease | NCT00004010 | Lymphoma | bleomycin sulfa... filgrastim ABVD regimen cyclophosphamid... dacarbazine doxorubicin hyd... etoposide prednisone procarbazine hy... vinblastine sul... vincristine sul... radiation thera... | - 21 Years | Children's Oncology Group | |
Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma | NCT00002840 | Brain and Centr... | lomustine procarbazine hy... vincristine sul... radiation thera... | 16 Years - 69 Years | European Organisation for Research and Treatment of Cancer - EORTC |